Cardiac Dysfunction in the Met Syndrome: Cross-talk between IR and bAR Signaling
Met 综合征中的心脏功能障碍:IR 和 bAR 信号传导之间的串扰
基本信息
- 批准号:9272923
- 负责人:
- 金额:$ 38.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:ADRBK1 geneAcuteAddressAdenylate CyclaseAdrenergic AgentsAffectAnimalsApoptosisAttenuatedBiosensorCaliforniaCardiacCardiac MyocytesCardiomyopathiesChronicCollaborationsComplexCouplingCross SyndromeCyclic AMPCyclic AMP-Dependent Protein KinasesDiabetes MellitusDietFatty acid glycerol estersFunctional disorderGene TargetingGenerationsGeneticGenetic TranscriptionGlucose IntoleranceGoalsHeartHeart failureHumanHyperinsulinismHyperlipidemiaHypertrophyIRS1 geneImpairmentInfusion proceduresInsulinInsulin ReceptorInsulin ResistanceIowaIsoproterenolKnock-outLaboratoriesLeftLeft Ventricular DysfunctionLeft Ventricular FunctionLeft Ventricular RemodelingLinkLiverMediatingMetabolicMetabolic DiseasesMolecularMusMuscle CellsMyocardialMyocardial dysfunctionNon-Insulin-Dependent Diabetes MellitusObesityOrganPhosphorylationPhysiologicalPopulationPreventionProductionProteinsRisk FactorsRoleSeriesSignal PathwaySignal TransductionSkeletal MuscleTestingUnited StatesUniversitiesVentricularVentricular RemodelingYangbaseconstrictiondesensitizationepidemiology studyglucose uptakein vivoinsulin sensitivityinsulin signalingmortalitymouse modelmutant mouse modelnovelphosphodiesterase IVphospholambanpressurepreventprotein degradationpublic health relevanceresponsetraffickingtype I diabeticwestern diet
项目摘要
DESCRIPTION (provided by applicant): Obesity, type 2 diabetes (T2DM) and insulin resistance are independent risk factors for heart failure, which affects a rapidly increasing segment of the US population. The long-term goal of this proposal is to understand the mechanisms linking these metabolic disorders and left ventricular (LV) dysfunction prior to and in concert with heart failure. Obesity is associated with insulin resistance, hyperlipidemia, glucose intolerance and hyperinsulinemia. Epidemiological studies suggest that hyperinsulinemia is an independent risk factor for heart failure. In humans and mouse models, the heart may retain its insulin sensitivity in terms of insulin's ability to activate IRS1, PI3K ad Akt signaling, despite insulin resistance in other organs such as the liver and skeletal muscle. This hyperinsulinemia also accelerates adverse LV remodeling in pressure overload hypertrophy and genetic reduction of insulin signaling in cardiomyocytes limits hypertrophic remodeling and reduces apoptosis in pressure overload, thereby preserving LV function. Our recent studies reveal that hyperinsulinemia desensitizes �R-mediated stimulation of cardiac contractility, which represents a novel mechanism linking insulin resistance, hyperinsulinemia and LV dysfunction. This proposal, will therefore focus on the hypothesis that hyperinsulinemia might attenuate LV contractility by directly impairing �or �-adrenergic (�) signaling. Specifically, activation of cardiomyocyte insulin receptors (IR) in hyperinsulinemic states, impairs � signaling via two distinct mechanisms: (1) Increased �R/Gi coupling that inhibits adenylyl cyclase and cAMP production, and (2) Increased expression of PDE4D that increases cAMP degradation. This multi PI proposal reflects an active collaboration by the laboratories of Evan Dale Abel (University of Iowa) and Yang Kevin Xiang (University of California -Davis). Our combined expertise in myocardial insulin signaling and myocardial adrenergic signaling will address this hypothesis in the following two specific aims. Aim 1 (Xiang). Will define the molecular mechanisms by which insulin impairs � signaling in cardiomyocytes by testing the following hypotheses: Insulin signaling increases �R/Gi coupling via a complex containing �R, IR, IRS, and GRK2 that inhibits adenylyl cyclase-mediated cAMP generation. Insulin signaling enhances cardiac PDE4 levels via �R-ERK dependent modulation of PDE4 transcription and protein turnover. Aim 2 (Abel). Will determine the physiological consequences of �-IR interactions in hearts in vivo by testing the hypotheses that: Acute or chronic hyperinsulinemia will impair myocardial � signaling and reduce contractility or inotropic reserve and that hyperinsulinemia in obesity, T2DM and heart failure will exacerbate cardiac dysfunction by impairing inotropic reserve. By using novel molecular biosensors to define subcellular adrenergic signaling domains in cardiomyocytes and a comprehensive array of mutant mouse models with perturbed IR or � signaling, we will dissect the mechanism for IR-� crosstalk that limits myocardial contractility in insulin resistant states.
描述(由申请人提供):肥胖、2型糖尿病(T2 DM)和胰岛素抵抗是心力衰竭的独立风险因素,影响了美国人口的快速增长部分。本提案的长期目标是了解这些代谢紊乱与心力衰竭前和心力衰竭时左心室(LV)功能障碍之间的联系机制。肥胖与胰岛素抵抗、高脂血症、葡萄糖耐受不良和高胰岛素血症有关。流行病学研究表明,高胰岛素血症是心力衰竭的独立危险因素。在人类和小鼠模型中,尽管其他器官(如肝脏和骨骼肌)存在胰岛素抵抗,但心脏可能在胰岛素激活IRS 1、PI 3 K和Akt信号传导的能力方面保持其胰岛素敏感性。这种高胰岛素血症还加速了压力超负荷肥大中的不利LV重构,并且心肌细胞中胰岛素信号传导的遗传减少限制了肥大重构并减少了压力超负荷中的细胞凋亡,从而保护了LV功能。我们最近的研究表明,高胰岛素血症脱敏R介导的心脏收缩力的刺激,这代表了一种新的机制连接胰岛素抵抗,高胰岛素血症和左室功能障碍。因此,这项建议将集中在高胰岛素血症可能通过直接损害β或β-肾上腺素能(β)信号而减弱LV收缩力的假设上。具体来说,高胰岛素血症状态下心肌细胞胰岛素受体(IR)的激活通过两种不同的机制损害β信号传导:(1)增加β R/Gi偶联,抑制腺苷酸环化酶和cAMP的产生,(2)增加PDE 4D的表达,增加cAMP降解。该多PI提案反映了Evan Dale Abel(爱荷华州大学)和Yang Kevin Xiang(加州-戴维斯大学)实验室的积极合作。我们在心肌胰岛素信号传导和心肌肾上腺素能信号传导方面的综合专业知识将在以下两个具体目标中解决这一假设。目标1(Xiang)。将通过测试以下假设来定义胰岛素损害心肌细胞中信号传导的分子机制:胰岛素信号传导通过含有R,IR,IRS和GRK 2的复合物增加R/Gi偶联,该复合物抑制腺苷酸环化酶介导的cAMP生成。胰岛素信号通过R-ERK依赖性调节PDE 4转录和蛋白质周转来增强心脏PDE 4水平。目标2(阿贝尔)。将通过测试以下假设来确定体内心脏中β-IR相互作用的生理后果:急性或慢性高胰岛素血症将损害心肌信号传导并降低收缩力或正性肌力储备,肥胖、2型糖尿病和心力衰竭中的高胰岛素血症将通过损害正性肌力储备而加剧心功能障碍。通过使用新型分子生物传感器来定义心肌细胞中的亚细胞肾上腺素能信号结构域以及一系列IR或β信号受到干扰的突变小鼠模型,我们将剖析IR-β串扰限制胰岛素抵抗状态下心肌收缩力的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E Dale Abel其他文献
E Dale Abel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E Dale Abel', 18)}}的其他基金
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation
OPA1 是雌激素介导的血小板过度活化调节剂
- 批准号:
10614311 - 财政年份:2022
- 资助金额:
$ 38.69万 - 项目类别:
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes
通过电磁场调节 ROS 治疗 2 型糖尿病
- 批准号:
10570226 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Modulating ROS by Electromagnetic Fields to Treat Type 2 Diabetes
通过电磁场调节 ROS 治疗 2 型糖尿病
- 批准号:
10393667 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
OPA1 an Estrogen-Mediated Modulator of Platelet Hyperactivation
OPA1 是雌激素介导的血小板过度活化调节剂
- 批准号:
10026343 - 财政年份:2018
- 资助金额:
$ 38.69万 - 项目类别:
Insulin Inhibition of beta-AR Signaling in the Myocardium
胰岛素对心肌 β-AR 信号传导的抑制
- 批准号:
9207133 - 财政年份:2015
- 资助金额:
$ 38.69万 - 项目类别:
Insulin Inhibition of beta-AR Signaling in the Myocardium
胰岛素对心肌 β-AR 信号传导的抑制
- 批准号:
8899989 - 财政年份:2015
- 资助金额:
$ 38.69万 - 项目类别:
Insulin Inhibition of beta-AR Signaling in the Myocardium
胰岛素对心肌 β-AR 信号传导的抑制
- 批准号:
9036439 - 财政年份:2015
- 资助金额:
$ 38.69万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Standard Grant